Implementation of product innovation as a result of R & D work (Q81147): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Label in wikidata changed)
(‎Created claim: summary (P836): “reference_reference_programme_aids”:SA.42799 (2015/X), public funding:Article 28 of Commission Regulation (EC) No 651/2014 ", the project is to be implemented in ICEM sp. z o.o. developed in a service stage of manufacturing product innovation in the form of products such as food supplements, food for special medical purposes, functional food and others, intended for the infection of Helicobacter pylori bacteria.The problem of Hp infections is w...)
Property / summary
 
“reference_reference_programme_aids”:SA.42799 (2015/X), public funding:Article 28 of Commission Regulation (EC) No 651/2014 ", the project is to be implemented in ICEM sp. z o.o. developed in a service stage of manufacturing product innovation in the form of products such as food supplements, food for special medical purposes, functional food and others, intended for the infection of Helicobacter pylori bacteria.The problem of Hp infections is widespread and of considerable importance.It may cause serious diseases including dyspesia, mucosal itis, heaths and stomach cancer.Hp infection is considered to be subject to action, irrespective of the occurrence or absence of symptoms of disease.As a preventive measure, Hp is often recommended.In addition, it is advantageous for those infected with Hp to receive certain nutrients, to assist the organism and to alleviate their disease.The implementation of product innovation will be achieved as much as possible through the acquisition of equipment:— capsule — sachets.They are necessary to start the production of innovative products in forms and forms, tailored to the different needs and preferences of consumers, as well as product categories.This will help the Company to produce the results obtained by providing consumers with a variety of products in various forms of application, with the possibility of modifying them through added ingredients (e.g. probiotics), which have a positive effect on Hp and mitigating disease symptoms.The result will be the introduction of the JBR of plant preparations into ICEM for the Hop infection in 2 forms:capsules and sachets.Innovation related to the specific characteristics, verified by the JBR in the in vitro studies of the product components.These are the desired properties of the preparations used in Hp infections:— anti-bacterial stimulation — stimulation inhibition resistance of Hp to the stomach cells and supporting their regeneration.I (English)
Property / summary: “reference_reference_programme_aids”:SA.42799 (2015/X), public funding:Article 28 of Commission Regulation (EC) No 651/2014 ", the project is to be implemented in ICEM sp. z o.o. developed in a service stage of manufacturing product innovation in the form of products such as food supplements, food for special medical purposes, functional food and others, intended for the infection of Helicobacter pylori bacteria.The problem of Hp infections is widespread and of considerable importance.It may cause serious diseases including dyspesia, mucosal itis, heaths and stomach cancer.Hp infection is considered to be subject to action, irrespective of the occurrence or absence of symptoms of disease.As a preventive measure, Hp is often recommended.In addition, it is advantageous for those infected with Hp to receive certain nutrients, to assist the organism and to alleviate their disease.The implementation of product innovation will be achieved as much as possible through the acquisition of equipment:— capsule — sachets.They are necessary to start the production of innovative products in forms and forms, tailored to the different needs and preferences of consumers, as well as product categories.This will help the Company to produce the results obtained by providing consumers with a variety of products in various forms of application, with the possibility of modifying them through added ingredients (e.g. probiotics), which have a positive effect on Hp and mitigating disease symptoms.The result will be the introduction of the JBR of plant preparations into ICEM for the Hop infection in 2 forms:capsules and sachets.Innovation related to the specific characteristics, verified by the JBR in the in vitro studies of the product components.These are the desired properties of the preparations used in Hp infections:— anti-bacterial stimulation — stimulation inhibition resistance of Hp to the stomach cells and supporting their regeneration.I (English) / rank
 
Normal rank

Revision as of 09:24, 4 March 2020

Project in Poland financed by DG Regio
Language Label Description Also known as
English
Implementation of product innovation as a result of R & D work
Project in Poland financed by DG Regio

    Statements

    0 references
    360,000.0 zloty
    0 references
    86,400.0 Euro
    13 January 2020
    0 references
    984,000.0 zloty
    0 references
    236,160.0 Euro
    13 January 2020
    0 references
    45.0 percent
    0 references
    9 May 2018
    0 references
    31 March 2019
    0 references
    OŚRODEK BADAWCZO-PRODUKCYJNY POLITECHNIKI ŁÓDZKIEJ "ICHEM" SP. Z O.O.
    0 references
    „Numer_referencyjny_programu_pomocowego: SA.42799(2015/X), przeznaczenie_pomocy_publicznej: art. 28 rozporządzenia Komisji nr 651/2014”Przedmiotem projektu jest wdrożenie w ICHEM sp. z o.o. opracowanej w Etapie usługowym, technologicznej innowacji produktowej w postaci wyrobów np. z kategorii suplementów diety, żywności specjalnego przeznaczenia medycznego, żywności funkcjonalnej i in., przeznaczonych dla osób zakażonych bakterią Helicobacter pylori. Problem zakażenia Hp jest powszechny i b. istotny. Może być przyczyną poważnych chorób m.in. dyspepsji, zapalenia błony śluzowej, wrzodów i raka żołądka. Uznaje się, że zakażenie Hp wymaga podjęcia działań, niezależnie od występowania lub braku objawów chorobowych. W ramach profilaktyki zaleca się często eradykację Hp. Dodatkowo korzystne jest przyjmowanie przez osoby zakażone Hp określonych składników odżywczych, wspomagających organizm i łagodzących objawy chorobowe. Wdrożenie innowacji produktowej będzie możliwie dzięki nabyciu urządzeń: -kapsułkarka -saszetkarka. Są on niezbędne do rozpoczęcia wytwarzania innowacyjnych wyrobów w formach i postaciach, dopasowanych do zróżnicowanych potrzeb i preferencji konsumentów, a także kategorii produktów. Dzięki temu Spółka wdroży do produkcji uzyskane wyniki badań, oferując konsumentom różnorodne produkty w różnych formach aplikacyjnych z możliwością ich modyfikowania poprzez dodawane składników (np. probiotyki), działających pozytywnie w zakażeniach Hp i łagodzących objawy chorobowe. Rezultatem będzie wprowadzenie do oferty ICHEM opracowanych przez JBR preparatów roślinnych, przeznaczonych dla osób zakażonych bakterią Hp w 2 formach: kapsułki i saszetki. Innowacja dot. szczególnych cech, zweryfikowanych przez JBR w badaniach in vitro składników produktu. Są to pożądane właściwości preparatów, stosowanych w zakażeniach Hp: -antybakteryjność -pobudzanie ukł. odpornościowego -hamowanie adhezji Hp do komórek żołądka i wspieranie ich regeneracji. I (Polish)
    0 references
    “reference_reference_programme_aids”:SA.42799 (2015/X), public funding:Article 28 of Commission Regulation (EC) No 651/2014 ", the project is to be implemented in ICEM sp. z o.o. developed in a service stage of manufacturing product innovation in the form of products such as food supplements, food for special medical purposes, functional food and others, intended for the infection of Helicobacter pylori bacteria.The problem of Hp infections is widespread and of considerable importance.It may cause serious diseases including dyspesia, mucosal itis, heaths and stomach cancer.Hp infection is considered to be subject to action, irrespective of the occurrence or absence of symptoms of disease.As a preventive measure, Hp is often recommended.In addition, it is advantageous for those infected with Hp to receive certain nutrients, to assist the organism and to alleviate their disease.The implementation of product innovation will be achieved as much as possible through the acquisition of equipment:— capsule — sachets.They are necessary to start the production of innovative products in forms and forms, tailored to the different needs and preferences of consumers, as well as product categories.This will help the Company to produce the results obtained by providing consumers with a variety of products in various forms of application, with the possibility of modifying them through added ingredients (e.g. probiotics), which have a positive effect on Hp and mitigating disease symptoms.The result will be the introduction of the JBR of plant preparations into ICEM for the Hop infection in 2 forms:capsules and sachets.Innovation related to the specific characteristics, verified by the JBR in the in vitro studies of the product components.These are the desired properties of the preparations used in Hp infections:— anti-bacterial stimulation — stimulation inhibition resistance of Hp to the stomach cells and supporting their regeneration.I (English)
    0 references

    Identifiers

    POIR.02.03.02-10-0011/18
    0 references